Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation

Targets of curative donor-derived graft-versus-myeloma (GVM) responses after allogeneic hematopoietic stem cell transplantation (HSCT) remain poorly defined, partly because immunity against minor histocompatibility Ags (mHAgs) complicates the elucidation of multiple myeloma (MM)–specific targets. We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Biernacki, Melinda A., Tai, Yu-tzu, Zhang, Guang Lan, Alonso, Anselmo, Zhang, Wandi, Prabhala, Rao, Zhang, Li, Munshi, Nikhil, Neuberg, Donna, Soiffer, Robert J., Ritz, Jerome, Alyea, Edwin P., Brusic, Vladimir, Anderson, Kenneth C., Wu, Catherine J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2012
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321874/
https://ncbi.nlm.nih.gov/pubmed/22267603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-11-388926
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars